Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Glutamine may help lessen neuropathy caused by chemotherapy. It is not yet known
whether glutamine is more effective than a placebo in treating neuropathy caused by
vincristine.
PURPOSE: This randomized phase II trial is studying glutamine to see how well it works
compared to a placebo in treating neuropathy caused by vincristine in young patients with
lymphoma, leukemia, or solid tumors.